Antitrust and Consumer Protection
Competition: Spring 2015, Vol. 24, No. 1
Content
- California Antitrust and Unfair Competition Law and Federal and State Procedural Law Developments
- Chair's Column
- Editor's Note
- How Viable Is the Prospect of Enforcement of Privacy Rights In the Age of Big Data? An Overview of Trends and Developments In Consumer Privacy Class Actions
- Keynote Address: a Conversation With the Honorable Kathryn Mickle Werdegar, Justice of the California Supreme Court
- Major League Baseball Is Exempt From the Antitrust Laws - Like It or Not: the "Unrealistic," "Inconsistent," and "Illogical" Antitrust Exemption For Baseball That Just Won't Go Away.
- Masthead
- Nowhere To Run, Nowhere To Hide: In the Age of Big Data Is Data Security Possible and Can the Enforcement Agencies and Private Litigation Ensure Your Online Information Remains Safe and Private? a Roundtable
- Restoring Balance In the Test For Exclusionary Conduct
- St. Alphonsus Medical Center-nampa and Ftc V St. Luke's Health System Ltd.: a Panel Discussion On This Big Stakes Trial
- St. Alphonsus Medical Center - Nampa, Inc., Et Al. and Federal Trade Commission, Et Al. V St. Luke's Health System, Ltd., and Saltzer Medical Group, P.a.: a Physicians' Practice Group Merger's Journey Through Salutary Health-related Goals, Irreparable Harm, Self-inflicted Wounds, and the Remedy of Divestiture
- The Baseball Exemption: An Anomaly Whose Time Has Run
- The Doctor Is In, But Your Medical Information Is Out Trends In California Privacy Cases Relating To Release of Medical Information
- The State of Data-breach Litigation and Enforcement: Before the 2013 Mega Breaches and Beyond
- The United States V. Bazaarvoice Merger Trial: a Panel Discussion Including Insights From Trial Counsel
- United States V. Bazaarvoice: the Role of Customer Testimony In Clayton Act Merger Challenges
- The Continuing Violations Doctrine: Limitation In Name Only, or a Resuscitation of the Clayton Act's Statute of Limitations?
THE CONTINUING VIOLATIONS DOCTRINE: LIMITATION IN NAME ONLY, OR A RESUSCITATION OF THE CLAYTON ACT’S STATUTE OF LIMITATIONS?
By Stephen McIntyre and Kenneth R. O’Rourke1
I. INTRODUCTION
Congress first gave private plaintiffs a right to sue for federal antitrust violations in 1914, when it passed the Clayton Antitrust Act.2 Congress did not initially enact a statute of limitations. For the next several decades, courts looked to state statutes to determine the applicable limitations period in each case.3 As a result, "a plaintiff injured in several jurisdictions [was] permitted to select as his forum the State with the most favorable statute," and defendants "remain[ed] in constant jeopardy until the longest period of limitations ha[d] transpired."4 Finally, in 1955, Congress took action to remedy the problem by mandating a "uniform statute of limitations applicable to all private treble damage actions."5 It enacted Section 4B of the Clayton Act, which requires antitrust plaintiffs to bring suit within four years from the time their cause of action accrues.6
Sixty years later, defendants once again face an unsettling lack of uniformity in federal antitrust actions. Though the Clayton Act imposes a four-year limitation on treble damage actions, several courts of appeals have created an exception that all but swallows the rule. These courts hold that the "continuing violations" doctrine permits a plaintiff to sue at any point after a defendant’s allegedly unlawful conduct has ceased, so long as inflated pricesâthe prototypical effect of an antitrust violationâpersist. This interpretation of the doctrine turns Section 4B on its head, permitting plaintiffs to keep the limitations period runningâand treble damages accumulatingâfor years after the underlying collusion has ended. Instead of a "uniform statute of limitations" with a definitive ending point, defendants now face a limitless statute of limitations depending on the jurisdiction in which a federal antitrust claim is litigated.